Useful links

National Institute for health and Care Excellence (NICE)


NHS England

  • Advice for secondary care (link)
  • Advice for primary care (link)
  • Advice for community based health, social, mental health and ambulance service (link)

National Institute for Health Research (NIHR)

  • Priority trials (link)

Specialist Pharmacy Service – COVID-19 resources

  • Summary of COVID-19 medicines guidance from professional and government bodies
    • Allergy and immunology (link)
    • Anaesthesia and pain (link)
    • Cancer (link)
    • Cardiovascular system disorders (link)
    • Critical care (link)
    • Diabetes (link)
    • Endocrine system disorders (link)
    • Eyes and vision (link)
    • Family planning (link)
    • Gastrointestinal disorders (link)
    • Haematological disorders (link)
    • Infection and infectious diseases (link)
    • Later life (link)
    • Learning disabilities (link)
    • Mental health and illness (link)
    • Musculo-skeletal disorders (link)
    • Neurological disorders (link)
    • Nutritional and inherited metabolic disorders (link)
    • Obstetrics and gynaecology (link)
    • Paediatric and neonatal medicine (link)
    • Palliative and End of Life Care (link)
    • Policy, Commissioning and Managerial (link)
    • Renal and urologic disorders (link)
    • Respiratory disorders (link)
    • Skin disorders (link)
    • Stroke (link)
    • Surgery (link)
    • Wounds and injuries (link)
  • Mental health
    • Summary of COVID-19 medicines guidance (link)
    • Administration of depot antipsychotic injections during COVID-19 in stable adult patients (link)
    • Clozapine drug monitoring during COVID-19 for stable adult patients (link)
    • Lithium drug monitoring during COVID-19 for stable adult patients (link)
  • Drug monitoring
    • Azathioprine, leflunomide, mercatopurine, and methotrexate, drug monitoring in primary care during COVID-19 (link)
    • Guidance on the management of drugs requiring monitoring during COVID-19 (link)
    • Drug monitoring: factors to consider during Covid-19 (link)
    • Ciclosporin drug monitoring in primary care during COVID-19 (link)
    • Clozapine drug monitoring during COVID-19 for stable adult patients (link)
    • Hydroxychloroquine drug monitoring during COVID-19 (link)
    • Lithium drug monitoring during COVID-19 for stable adult patients (link)
    • Penicillamine drug monitoring in primary care during COVID-19 (link)
    • Sulfasalazine drug monitoring in primary care during COVID-19 (link)
  • Injectable medicines
    • General
      • Options for the Provision of Ready to Administer IVs to Support Clinical Areas (link)
      • Use of gravity infusions and bolus injections in adults during COVID-19 (link)
    • Intensive care
      • Batch Worksheets for S10 Preparation of Injectable Medicines for ICU (link)
      • Preparation of injectable medicines at the ITU bedside: quick reference guides (link)
    • Syringe compatibility information
      • Mixing critical care injectable medicines together in a syringe (link)
      • Alfentanil hydrochloride (link)
      • Fentanyl citrate (link)
      • Midazolam hydrochloride (link)
      • Propofol (link)
    • General
      • Management of patients currently on warfarin during Covid-19 (link)
      • Use of PGDs in pandemics (link)